Related Experiment Videos
Axillary lymph node metastasis from an occult breast cancer
Cancer
|June 15, 1981
Summary
Occult breast carcinoma presenting as axillary lymph node enlargement should be treated as breast cancer. Even without discovering the primary breast tumor, survival rates are comparable to known breast cancers with nodal metastasis.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Axillary lymph node metastasis can be the initial presentation of occult breast carcinoma.
- Identifying the primary breast tumor is crucial for accurate staging and treatment planning.
Purpose of the Study:
- To evaluate the clinical outcomes and diagnostic yield of investigating axillary lymphadenopathy of unknown origin.
- To determine optimal management strategies for patients with isolated axillary nodal metastasis suspected to be from an occult breast primary.
Main Methods:
- Retrospective review of 29 cases with axillary lymph node carcinoma.
- Analysis of diagnostic procedures including mammography and pathological examination.
- Comparison of metastasis-free survival rates based on primary tumor discovery.
Main Results:
- In 16 of 29 patients (55%), a primary breast tumor was identified.
- In 13 patients (45%), the breast tumor remained undiscovered.
- Metastasis-free survival rates were similar between patients with and without a discovered primary tumor.
- Mammography identified the primary tumor in 75% of positive cases but negative mammograms did not exclude breast origin.
- Pathological examination revealed breast carcinoma in 44% of patients with negative mammograms.
Conclusions:
- Carcinoma in an axillary node should be managed as breast cancer, irrespective of primary tumor detection.
- Extensive investigations for extramammary primary sites are often unproductive and should be selective.
- Mammography is valuable but not definitive; pathological examination is essential even with negative mammograms.